DEF: Medical Properties Trust Sets 2026 Annual Meeting Date
Proxy Statement
Medical Properties Trust announces its 2026 Annual Meeting of Stockholders, scheduled for May 28, 2026, in Birmingham, Alabama, with proxy materials and the annual report being made available on or about April 13, 2026.
Summary
- Medical Properties Trust (MPT) is holding its 2026 Annual Meeting of Stockholders on May 28, 2026, at 10:30 a.m. Central Time at the UAB Collat School of Business in Birmingham, Alabama.
- Stockholders of record as of March 19, 2026, are eligible to vote.
- Key proposals include the election of nine director nominees, ratification of PricewaterhouseCoopers LLP as the independent auditor for 2026, an advisory vote on executive compensation, and approval of the Second Amended and Restated 2019 Equity Incentive Plan.
- The company is making proxy materials and the 2025 Annual Report available electronically via the internet.
- MPT highlights its focus in 2025 on balance sheet improvement, capital allocation, and earnings stabilization, noting a stronger balance sheet and improved liquidity.
- Executive compensation is structured around a pay-for-performance philosophy with rigorous performance hurdles for both short-term and long-term incentives.
- The company emphasizes strong corporate governance practices, including board refreshment, independence, and stockholder engagement.
- Corporate responsibility efforts in 2025 included environmental sustainability initiatives, employee development, and social responsibility programs.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this filing as neutral to slightly positive, reflecting a company focused on governance and compensation alignment, with some positive operational metrics despite ongoing challenges in the healthcare real estate sector.
Positives
- The company has taken actions to strengthen its balance sheet, improve liquidity, and enhance portfolio quality in 2025.
- Total Portfolio EBITDARM Rent Coverage increased to 2.6x for TTM 2025, up from 2.4x in TTM 2024.
- Cash rent increased by 12% in 2025 over 2024, with projected 2026 annual cash rent of approximately $1.0 billion.
- 2025 Total Shareholder Return (TSR) was +33%, ranking in the 63rd percentile relative to the Healthcare REIT Peer Group.
- The Board of Directors is 78% independent.
- The company has a strong commitment to corporate governance, with robust practices and policies in place.
- Significant progress in environmental sustainability, including Green Lease Leaders Gold Certification and improved ESG scores.
- The company's three-year average burn rate for equity awards is 0.45%, well below the ISS industry standard of 1.05%.
Negatives
- No portion of the 2024 performance awards has been achieved due to a $7.00 stock price goal.
- The 2025 TSR Performance Award remains out-of-the-money despite a 33% TSR in 2025, due to a rigorous 20% minimum TSR threshold.
- The company has experienced lower Say-On-Pay support in recent years, with 58.3% approval in 2025.
- The CEO and CFO realized less than two-thirds of their total compensation reported in the Summary Compensation Table in 2025 due to unearned performance awards.
- The filing indicates that for the 2023 Performance Award, the 3-Year EBITDA metric achieved less than the threshold, resulting in 0% earned for that component.
Risks
- Revenue concentration and the financial health and operational status of the Company's tenants and operators are overseen by the Risk Committee.
- The Risk Committee monitors risks related to business continuity, modifications to strategies, industry trends, general economic conditions, entrance into new markets, privacy concerns and security breaches, and federal and state regulations.
- Cybersecurity is a key focus, with the Board overseeing enterprise risk management processes addressing material risks from cybersecurity threats.
- The company's 2024 Stock Price Performance Award has a $7.00 stock price goal, which requires a 67% increase over the grant date price before any portion is earned.
Future Outlook
The company is positioned for continued stabilization and organic growth through increased rent collections, following actions taken in 2025 to strengthen its balance sheet, improve liquidity, and enhance portfolio quality.
Management Comments
- "Throughout 2025, we have taken actions to strengthen and position the Company for long-term success by focusing on: Balance Sheet Improvement, Allocation of Capital, and Stabilization of Earnings."
- "Despite a challenging operating and capital markets environment, we remained focused on what matters most to our stockholders: preserving liquidity, improving our balance sheet, enhancing portfolio quality, and stabilizing earnings."
- "We believe in paying for performance and aligning our NEOs interests with those of our stockholders by tying a significant portion of our NEOs compensation to our long-term financial and growth objectives, with approximately 74% of our CEOs target compensation delivered in the form of equity-based awards."
- "Our executive compensation program is designed to ensure that pay outcomes are directly aligned with long-term stockholder value creation."
- "We are committed to strong corporate governance, and our Board has adopted robust governance practices and policies."
Industry Context
StockSavvy.ai notes that Medical Properties Trust's focus on balance sheet improvement, capital allocation, and earnings stabilization aligns with broader trends in the healthcare REIT sector, which has faced challenges related to operator financial health and rising interest rates. The company's efforts to manage debt and enhance portfolio quality are critical for navigating the current economic climate.
Comparison to Industry Standards
- The company's 2025 TSR of +33% ranked in the 63rd percentile relative to the U.S. Real Estate Health Care Index constituents.
- The maximum cash revenue growth target for annual bonuses was 8.5%, which is higher than the industry average NOI growth of 5% as reported by Nareit.
- The company's three-year average burn rate for equity awards (0.45%) is well below the Institutional Shareholder Services (ISS) industry standard of 1.05%.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Refreshment | The company has taken meaningful steps to refresh its Board and create an effective mix of diverse experience. | Enhances board effectiveness through a blend of institutional knowledge and fresh perspectives. | |
| Director Independence | The Board is currently 78% independent. | Meets and exceeds typical independence standards, promoting objective oversight. | |
| Corporate Governance Practices | Adoption of robust governance practices including proxy access, majority voting, lead independent director, and no poison pill. | Demonstrates a commitment to strong shareholder rights and transparent governance. | |
| Stockholder Engagement | Active engagement with stockholders regarding executive compensation and other matters. | Aims to incorporate stockholder feedback into company policies and decisions. |
Related Party Transactions
- During 2025, Mr. Aldag had two family members employed by the Company; Mr. Hamner had two family members employed by the Company; and Mr. Stewart had one family member employed by the Company. These family members were employed in non-executive positions with compensation comparable to similar roles.
- The Company paid Johnson Healthcare Real Estate approximately $2.5 million in 2025 for construction project management and facility review oversight. Mr. Aldag has a family member employed by Johnson in a non-executive capacity.
Stakeholder Impact
- Shareholders are encouraged to vote on key proposals, including director elections and executive compensation, with the company emphasizing alignment of executive pay with stockholder value.
- Employees are supported through development opportunities and a dynamic workplace, with recognition as a Best Place to Work.
- Tenants and communities are indirectly impacted by the company's focus on portfolio quality, financial stability, and corporate responsibility initiatives.
Next Steps
- Stockholders are encouraged to vote by mail, phone, or internet.
- The company will hold its 2026 Annual Meeting of Stockholders on May 28, 2026.
- The company will continue to focus on balance sheet improvement, capital allocation, and earnings stabilization.
Key Dates
| Date | Description |
|---|---|
| 2025-12-31 | Year-end for outstanding equity awards and TSR performance awards. |
| 2026-01-01 | Vesting date for certain shares related to the 2023 Performance Award. |
| 2026-03-19 | Record date for determining stockholders entitled to receive notice of and vote at the Annual Meeting. |
| 2026-04-13 | Date of the Notice of Annual Meeting of Stockholders and Proxy Statement. |
| 2026-05-28 | Date of the 2026 Annual Meeting of Stockholders. |
| 2027-01-13 | Deadline for submitting stockholder proposals for the 2027 Annual Meeting (unless meeting date is significantly advanced or delayed). |
| 2027-03-29 | Deadline for universal proxy nominations of directors for the 2027 Annual Meeting (unless meeting date is significantly advanced or delayed). |
Recommendation
holdThe filing is primarily procedural, detailing the upcoming annual meeting and related proposals. While the company highlights efforts in balance sheet improvement and executive compensation alignment, there are no significant new financial results or strategic shifts that would warrant a buy or sell recommendation at this time. The company's performance metrics show some positive trends, but the unearned performance awards and lower Say-On-Pay support suggest ongoing challenges that warrant a 'hold' stance.
Keywords
Medical Properties Trust, MPT, Proxy Statement, Annual Meeting, Executive Compensation, Equity Incentive Plan, Director Election, Independent Auditor, Corporate Governance, REIT
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.